RECRUITING

Entire-body PET Scans for Multiple Sclerosis

Conditions

Multiple Sclerosis Entire-body PET imaging

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.

Official Title

Exploratory Study of Entire-body PET Scans for Multiple Sclerosis

Quick Facts

Study Start:2023-04-30

Study Completion:2024-10-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT04390009

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 55 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT

Inclusion Criteria	Exclusion Criteria
* Multiple sclerosis (MS) patients diagnosed by a credentialed neurologist experienced with care of multiple sclerosis patients. * Normal healthy subjects. * Willing and able to lie motionless on the PET-CT scanner bed for at least 10 minutes and up to 20 minutes for the duration of the PET-CT medical imaging scan.	* Any additional complicating medical illness other than MS including any other neuropsychiatric illness unrelated to MS diagnosed prior to the onset of initial symptoms of MS. * Pregnancy or breast feeding. * Diabetes or other metabolic-endocrine disorders. * Any known concomitant acute infection. * History of metastatic or locally invasive cancer. * Recent surgery, chemotherapy or radiation therapy.

Inclusion Criteria

Exclusion Criteria

* Multiple sclerosis (MS) patients diagnosed by a credentialed neurologist experienced with care of multiple sclerosis patients.
* Normal healthy subjects.
* Willing and able to lie motionless on the PET-CT scanner bed for at least 10 minutes and up to 20 minutes for the duration of the PET-CT medical imaging scan.

* Any additional complicating medical illness other than MS including any other neuropsychiatric illness unrelated to MS diagnosed prior to the onset of initial symptoms of MS.
* Pregnancy or breast feeding.
* Diabetes or other metabolic-endocrine disorders.
* Any known concomitant acute infection.
* History of metastatic or locally invasive cancer.
* Recent surgery, chemotherapy or radiation therapy.

Contacts and Locations

Study Contact

Carl Taswell, MD, PhD

CONTACT

949-481-3121

ctaswell@brainhealthalliance.org

Principal Investigator

Carl Taswell, MD, PhD

PRINCIPAL_INVESTIGATOR

Brain Health Alliance

Study Locations (Sites)

Brain Health Alliance

Ladera Ranch, California, 92694

United States

Collaborators and Investigators

Sponsor: Brain Health Alliance

Carl Taswell, MD, PhD, PRINCIPAL_INVESTIGATOR, Brain Health Alliance

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-30

Study Completion Date2024-10-30

Study Record Updates

Study Start Date2023-04-30

Study Completion Date2024-10-30

Terms related to this study

Keywords Provided by Researchers

Multiple Sclerosis
Entire-body PET imaging

Additional Relevant MeSH Terms

Multiple Sclerosis